Supplements
Editor-in-Chief Melissa Norton, MD
Biology Editor Penelope Webb, PhD
In-house Editor Sabina Alam PhD
BMC Neuroscience publishes selected research, proceedings and collections of thematic reviews as supplements. All articles published in supplements are subject to peer review and are free to access online. The journal also publishes supplements containing meeting abstracts.
Contents of Volume 9 Suppl 2
Proceedings of the 8th International Conference on Alzheimer's Disease Drug Discovery
Reviews
from 8th International Conference on Alzheimer's Disease Drug Discovery
New York, NY, USA. 15
16 October 2007
Edited by Howard Fillit
The publication of this supplement was made possible by the generous support of the conference sponsors: Forest Laboratories, Inc.; Bellus Health Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; Esai, Inc., Ortho-McNeil Neurologics, Inc.; Sanofi-Aventis US, Inc.; Schering-Plough; Accera, Inc.; Acumen Pharmaceuticals, Inc.; Pfizer Inc.; and Wyeth Research.
Review
Small molecule activators of the Trk receptors for neuroprotection Nicholas JG Webster, Michael C Pirrung BMC Neuroscience 2008, 9 (Suppl 2):S1 (3 December 2008) [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Review
Physiological and pathological aspects of A in iron homeostasis via 5'UTR in the APP mRNA and the therapeutic use of iron-chelators Yael Avramovich-Tirosh, Tamar Amit, Orit Bar-Am, Orly Weinreb, Moussa BH Youdim BMC Neuroscience 2008, 9 (Suppl 2):S2 (3 December 2008) [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Review
The potential of hematopoietic growth factors for treatment of Alzheimer's disease: a mini-review Juan Sanchez-Ramos, Shijie Song, Chuanhai Cao, Gary Arendash BMC Neuroscience 2008, 9 (Suppl 2):S3 (3 December 2008) [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Review
Selective amyloid- lowering agents Michael S Wolfe BMC Neuroscience 2008, 9 (Suppl 2):S4 (3 December 2008) [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Review
Preventing -amyloid fibrillization and deposition: -sheet breakers and pathological chaperone inhibitors Thomas Wisniewski, Martin Sadowski BMC Neuroscience 2008, 9 (Suppl 2):S5 (3 December 2008) [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Review
Therapeutic potential of resveratrol in Alzheimer's disease Val rie Vingtdeux, Ute Dreses-Werringloer, Haitian Zhao, Peter Davies, Philippe Marambaud BMC Neuroscience 2008, 9 (Suppl 2):S6 (3 December 2008) [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Review
Heat shock protein 90: translation from cancer to Alzheimer's disease treatment? Wenjie Luo, Anna Rodina, Gabriela Chiosis BMC Neuroscience 2008, 9 (Suppl 2):S7 (3 December 2008) [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Review
NADPH oxidase as a therapeutic target in Alzheimer's disease Michelle L Block BMC Neuroscience 2008, 9 (Suppl 2):S8 (3 December 2008) [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Review
Structure and regulation of MARK, a kinase involved in abnormal phosphorylation of Tau protein Thomas Timm, Alexander Marx, Saravanan Panneerselvam, Eckhard Mandelkow, Eva-Maria Mandelkow BMC Neuroscience 2008, 9 (Suppl 2):S9 (3 December 2008) [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Review
Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies Jianhua Zhou, Qingming Yu, Tie Zou BMC Neuroscience 2008, 9 (Suppl 2):S10 (3 December 2008) [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Review
Allopregnanolone-induced rise in intracellular calcium in embryonic hippocampal neurons parallels their proliferative potential Jun Ming Wang, Roberta Diaz Brinton BMC Neuroscience 2008, 9 (Suppl 2):S11 (3 December 2008) [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Review
The p38 mitogen-activated protein kinase as a central nervous system drug discovery target Aaron S Borders, Lucia de Almeida, Linda J Van Eldik, D Martin Watterson BMC Neuroscience 2008, 9 (Suppl 2):S12 (3 December 2008) [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Review
Immune defects in Alzheimer's disease: new medications development John R Cashman, Senait Ghirmai, Kenneth J Abel, Milan Fiala BMC Neuroscience 2008, 9 (Suppl 2):S13 (3 December 2008) [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Review
Development of cognitive enhancers based on inhibition of insulin-regulated aminopeptidase Siew Yeen Chai, Holly R Yeatman, Michael W Parker, David B Ascher, Philip E Thompson, Hayley T Mulvey, Anthony L Albiston BMC Neuroscience 2008, 9 (Suppl 2):S14 (3 December 2008) [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ] [Cited on BioMed Central ]
Review
Cognitive-enhancing effects of angiotensin IV Paul R Gard BMC Neuroscience 2008, 9 (Suppl 2):S15 (3 December 2008) [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ]
Review
Hypometabolism as a therapeutic target in Alzheimer's disease Lauren C Costantini, Linda J Barr, Janet L Vogel, Samuel T Henderson BMC Neuroscience 2008, 9 (Suppl 2):S16 (3 December 2008) [Abstract ] [Full text ] [PDF ] [PubMed ] [Related articles ] [Cited on BioMed Central ]